Patent details

EP1503790 Title: INTRACRANIAL TREATMENT OF NEUROPSYCHIATRIC DISORDERS BY CLOSTRIDIAL NEUROTOXINS SUCH AS BOTULINUM TOXIN

Basic Information

Publication number:
EP1503790
PCT Application Number:
PCT/US/2003/011416
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP037183837
PCT Publication Number:
WO/2003/094955
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
INTRACRANIAL TREATMENT OF NEUROPSYCHIATRIC DISORDERS BY CLOSTRIDIAL NEUROTOXINS SUCH AS BOTULINUM TOXIN
French Title of Invention:
TRAITEMENT INTRACRANIEN DE TROUBLES NEUROPSYCHIATRIQUES PAR DES NEUROTOXINES CLOSTRIDIENNES TELLES QUE LA TOXINE BOTULINIQUE
German Title of Invention:
INTRAKRANIALE BEHANDLUNG NEUROPSYCHIATRISCHER KRANKHEITEN MIT CLOSTRIDIUM NEUROTOXINEN WIE BOTULINUS TOXIN
SPC Number:

Dates

Filing date:
11/04/2003
Grant date:
17/09/2008
EP Publication Date:
17/09/2008
PCT Publication Date:
20/11/2003
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/02/2005
EP B1 Publication Date:
17/09/2008
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
11/04/2009
Expiration date:
11/04/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/04/2003
 
 

Name:
ALLERGAN INC.
Address:
2525 Dupont Drive, Irvine CA 92612, United States (US)

Inventor

Name:
DONOVAN Stephen
Address:
United States (US)

Priority

Priority Number:
143078
Priority Date:
10/05/2002
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/48;
Filing date Document type Number of pages